EDGAR Filing Documents for 0001144204-12-056392

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0001144204-12-056392

Filing Date

2012-10-16

Accepted

2012-10-16 16:45:58

Documents

Period of Report

2012-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-K/A	v324681_10ka.htm	10-K/A	39404
	Complete submission text file	0001144204-12-056392.txt		6290442

Data Files

Seq	Description	Document	Type	Size
2	XBRL INSTANCE DOCUMENT	boph-20120630.xml	EX-101.INS	807525
3	XBRL TAXONOMY EXTENSION SCHEMA	boph-20120630.xsd	EX-101.SCH	84222
4	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	boph-20120630_cal.xml	EX-101.CAL	40260
5	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	boph-20120630_def.xml	EX-101.DEF	358464
6	XBRL TAXONOMY EXTENSION LABEL LINKBASE	boph-20120630_lab.xml	EX-101.LAB	547475
7	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	boph-20120630_pre.xml	EX-101.PRE	466403

Mailing Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD, ZHIFU DISTRICT YANTAI, SHANDONG PROVINCE F4 264000

Business Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD, ZHIFU DISTRICT YANTAI, SHANDONG PROVINCE F4 264000 86-535-6763559

Bohai Pharmaceuticals Group, Inc. (Filer) CIK: 0001443242 (see all company filings)